United States Prostate Specific Antigen (PSA) Testing Market Report 2021
- QYR645918
- 103 Pages
- August 2016
- Diagnostic and Biotech
Sales, means the sales volume of Prostate Specific Antigen (PSA) Testing
Revenue, means the sales value of Prostate Specific Antigen (PSA) Testing
This report studies sales (consumption) of Prostate Specific Antigen (PSA) Testing in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Abbott Laboratories, Inc
Bayer AG
Beckman Coulter, Inc
GE Helathcare
GlaxoSmithKline, plc
Novartis Pharma AG
UroLogix, Inc
Bristol - Myers Squibb Company
AstraZeneca plc
Johnson & Johnson Diagnostics
BioChem Pharma
Pharmacia Delfia
Roche Diagnostics
Olympus
Tosho
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Free Prostate Specific Antigen Test
Complex Prostate Specific Antigen Test
Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test
Split by applications, this report focuses on sales, market share and growth rate of Prostate Specific Antigen (PSA) Testing in each application, can be divided into
Application 1
Application 2
Application 3
United States Prostate Specific Antigen (PSA) Testing Market Report 2021
1 Prostate Specific Antigen (PSA) Testing Overview
1.1 Product Overview and Scope of Prostate Specific Antigen (PSA) Testing
1.2 Classification of Prostate Specific Antigen (PSA) Testing
1.2.1 Free Prostate Specific Antigen Test
1.2.2 Complex Prostate Specific Antigen Test
1.2.3 Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test
1.3 Applications of Prostate Specific Antigen (PSA) Testing
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 USA Market Size (Value and Volume) of Prostate Specific Antigen (PSA) Testing (2011-2021)
1.4.1 USA Prostate Specific Antigen (PSA) Testing Sales, Revenue and Price (2011-2021)
1.4.2 USA Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2011-2021)
1.4.3 USA Prostate Specific Antigen (PSA) Testing Revenue and Growth Rate (2011-2021)
2 USA Prostate Specific Antigen (PSA) Testing Competition by Manufacturers
2.1 USA Prostate Specific Antigen (PSA) Testing Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Prostate Specific Antigen (PSA) Testing Revenue and Share by Manufactures (2015 and 2016)
3 USA Prostate Specific Antigen (PSA) Testing (Volume and Value) by Type
3.1 USA Prostate Specific Antigen (PSA) Testing Sales and Market Share by Type (2011-2021)
3.2 USA Prostate Specific Antigen (PSA) Testing Revenue and Market Share by Type (2011-2021)
4 USA Prostate Specific Antigen (PSA) Testing (Volume) by Application
5 USA Prostate Specific Antigen (PSA) Testing Manufacturers Analysis
5.1 Abbott Laboratories, Inc
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Prostate Specific Antigen (PSA) Testing Product Type and Technology
5.1.2.1 Free Prostate Specific Antigen Test
5.1.2.2 Complex Prostate Specific Antigen Test
5.1.3 Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Abbott Laboratories, Inc (2015 and 2016)
5.2 Bayer AG
5.2.1 Company Basic Information,Manufacturing Base and Competitors
5.2.2 Medical Devices Product Type and Technology
5.2.2.1 Free Prostate Specific Antigen Test
5.2.2.2 Complex Prostate Specific Antigen Test
5.2.3 Medical Devices Sales, Revenue, Price of Bayer AG (2015 and 2016)
5.3 Beckman Coulter, Inc
5.3.1 Company Basic Information,Manufacturing Base and Competitors
5.3.2 Beckman Coulter, Inc Product Type and Technology
5.3.2.1 Free Prostate Specific Antigen Test
5.3.2.2 Complex Prostate Specific Antigen Test
5.3.3 Beckman Coulter, Inc Sales, Revenue, Price of Beckman Coulter, Inc (2015 and 2016)
5.4 GE Helathcare
5.4.1 Company Basic Information,Manufacturing Base and Competitors
5.4.2 AstraZeneca plc Product Type and Technology
5.4.2.1 Free Prostate Specific Antigen Test
5.4.2.2 Complex Prostate Specific Antigen Test
5.4.3 GE Helathcare Sales, Revenue, Price of GE Helathcare (2015 and 2016)
5.5 GlaxoSmithKline, plc
5.5.1 Company Basic Information,Manufacturing Base and Competitors
5.5.2 GlaxoSmithKline, plc Product Type and Technology
5.5.2.1 Free Prostate Specific Antigen Test
5.5.2.2 Complex Prostate Specific Antigen Test
5.5.3 GlaxoSmithKline, plc Sales, Revenue, Price of GlaxoSmithKline, plc (2015 and 2016)
5.6 Novartis Pharma AG
5.6.1 Company Basic Information,Manufacturing Base and Competitors
5.6.2 Novartis Pharma AG Product Type and Technology
5.6.2.1 Free Prostate Specific Antigen Test
5.6.2.2 Complex Prostate Specific Antigen Test
5.6.3 Novartis Pharma AG Sales, Revenue, Price of Novartis Pharma AG (2015 and 2016)
5.7 UroLogix, Inc
5.7.1 Company Basic Information,Manufacturing Base and Competitors
5.7.2 UroLogix, Inc Product Type and Technology
5.7.2.1 Free Prostate Specific Antigen Test
5.7.2.2 Complex Prostate Specific Antigen Test
5.7.3 UroLogix, Inc Sales, Revenue, Price of UroLogix, Inc (2015 and 2016)
5.8 Bristol - Myers Squibb Company
5.8.1 Company Basic Information,Manufacturing Base and Competitors
5.8.2 Bristol - Myers Squibb Company Product Type and Technology
5.8.2.1 Free Prostate Specific Antigen Test
5.8.2.2 Complex Prostate Specific Antigen Test
5.8.3 Bristol - Myers Squibb Company Sales, Revenue, Price of Bristol - Myers Squibb Company (2015 and 2016)
5.9 AstraZeneca plc
5.9.1 Company Basic Information,Manufacturing Base and Competitors
5.9.2 AstraZeneca plc Product Type and Technology
5.9.2.1 Free Prostate Specific Antigen Test
5.9.2.2 Complex Prostate Specific Antigen Test
5.9.3 AstraZeneca plc Sales, Revenue, Price of AstraZeneca plc (2015 and 2016)
5.10 Johnson & Johnson Diagnostics
5.10.1 Company Basic Information,Manufacturing Base and Competitors
5.10.2 Johnson & Johnson Diagnostics Product Type and Technology
5.10.2.1 Free Prostate Specific Antigen Test
5.10.2.2 Complex Prostate Specific Antigen Test
5.10.3 Johnson & Johnson Diagnostics Sales, Revenue, Price of Johnson & Johnson Diagnostics (2015 and 2016)
5.11 BioChem Pharma
5.12 Pharmacia Delfia
5.13 Roche Diagnostics
5.14 Olympus
5.15 Tosho
6 Prostate Specific Antigen (PSA) Testing Technology and Development Trend
6.1 Prostate Specific Antigen (PSA) Testing Technology Analysis
6.2 Prostate Specific Antigen (PSA) Testing Technology Development Trend
7 Research Findings and Conclusion
Figure Picture of Prostate Specific Antigen (PSA) Testing
Table Classification of Prostate Specific Antigen (PSA) Testing
Figure USA Sales Market Share of Prostate Specific Antigen (PSA) Testing by Type in 2015
Figure Free Prostate Specific Antigen Test Picture
Figure Complex Prostate Specific Antigen Test Picture
Figure Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test Picture
Table Applications of Prostate Specific Antigen (PSA) Testing
Figure USA Sales Market Share of Prostate Specific Antigen (PSA) Testing by Application in 2015
Table USA Prostate Specific Antigen (PSA) Testing Sales, Revenue and Price (2011-2021)
Figure USA Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2011-2021)
Figure USA Prostate Specific Antigen (PSA) Testing Revenue and Growth Rate (2011-2021)
Table USA Prostate Specific Antigen (PSA) Testing Sales of Key Manufacturers (2015 and 2016)
Table USA Prostate Specific Antigen (PSA) Testing Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Prostate Specific Antigen (PSA) Testing Sales Share by Manufacturers
Figure 2016 Prostate Specific Antigen (PSA) Testing Sales Share by Manufacturers
Table USA Prostate Specific Antigen (PSA) Testing Revenue by Manufacturers (2015 and 2016)
Table USA Prostate Specific Antigen (PSA) Testing Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Prostate Specific Antigen (PSA) Testing Revenue Share by Manufacturers
Table 2016 USA Prostate Specific Antigen (PSA) Testing Revenue Share by Manufacturers
Table USA Prostate Specific Antigen (PSA) Testing Sales and Market Share by Type (2011-2021)
Table USA Prostate Specific Antigen (PSA) Testing Sales Share by Type (2011-2021)
Figure Sales Market Share of Prostate Specific Antigen (PSA) Testing by Type (2011-2021)
Figure USA Prostate Specific Antigen (PSA) Testing Sales Growth Rate by Type (2011-2021)
Table USA Prostate Specific Antigen (PSA) Testing Revenue and Market Share by Type (2011-2021)
Table USA Prostate Specific Antigen (PSA) Testing Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Prostate Specific Antigen (PSA) Testing by Type (2011-2021)
Figure USA Prostate Specific Antigen (PSA) Testing Revenue Growth Rate by Type (2011-2021)
Table USA Prostate Specific Antigen (PSA) Testing Sales and Market Share by Application (2011-2021)
Table USA Prostate Specific Antigen (PSA) Testing Sales Share by Application (2011-2021)
Figure Sales Market Share of Prostate Specific Antigen (PSA) Testing by Application (2011-2021)
Figure USA Prostate Specific Antigen (PSA) Testing Sales Growth Rate by Application (2011-2021)
Table Abbott Laboratories, Inc Basic Information List
Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Abbott Laboratories, Inc (2015 and 2016)
Table Bayer AG Basic Information List
Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Bayer AG (2015 and 2016)
Table Beckman Coulter, Inc Basic Information List
Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Beckman Coulter, Inc (2015 and 2016)
Table GE Helathcare Basic Information List
Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of GE Helathcare (2015 and 2016)
Table GlaxoSmithKline, plc Basic Information List
Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of GlaxoSmithKline, plc (2015 and 2016)
Table Novartis Pharma AG Basic Information List
Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Novartis Pharma AG (2015 and 2016)
Table UroLogix, Inc Basic Information List
Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of UroLogix, Inc (2015 and 2016)
Table Bristol - Myers Squibb Company Basic Information List
Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Bristol - Myers Squibb Company (2015 and 2016)
Table AstraZeneca plc Basic Information List
Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of AstraZeneca plc (2015 and 2016)
Table Johnson & Johnson Diagnostics Basic Information List
Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Johnson & Johnson Diagnostics (2015 and 2016)
Table BioChem Pharma Basic Information List
Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of BioChem Pharma (2015 and 2016)
Table Pharmacia Delfia Basic Information List
Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Pharmacia Delfia (2015 and 2016)
Table Roche Diagnostics Basic Information List
Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Roche Diagnostics (2015 and 2016)
Table Olympus Basic Information List
Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Olympus (2015 and 2016)
Table Tosho Basic Information List
Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Tosho (2015 and 2016)
Similar Reports
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
- Publish Date: September 1, 2016
- $5370
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
- Publish Date: May 24, 2017
- $5370
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...
- Publish Date: May 24, 2017
- $5370
